Synthesis and Combination Studies of Novel Dipeptide Nitriles with Curcumin for a Potent Synergistic Action Against Rhodesain, Cysteine Protease of Trypanosoma brucei rhodesiense
Open Access
- 5 June 2025
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (6) , 847
Abstract
Background/Objectives: Rhodesain is a cysteine protease crucial for the life cycle of Trypanosoma brucei rhodesiense, a parasite that causes the lethal form of human African trypanosomiasis. For these reasons, rhodesain is considered an important target for the drug discovery process of novel antitrypanosomal agents. Methods: In the present work, we carried out a combination study of two novel synthetic nitriles, Nitrile 1 and Nitrile 2, with curcumin, the golden multitarget nutraceutical obtained from Curcuma longa L., which we demonstrated to inhibit rhodesain in a non-competitive manner. We calculated the combination index (CI) in both the combination studies by using the Chou and Talalay method. Results: Comparing the CI values of the combinations Nitrile 1 + curcumin and Nitrile 2 + curcumin, we assessed that the inhibitory effect of the combination Nitrile 2 + curcumin against rhodesain was much more potent than that of the other combination. At the IC50 value, in the case of the combination Nitrile 1 + curcumin an additive effect occurred, while in the case of Nitrile 2 + curcumin, we observed a moderate synergism: at 99% of the effect, the synergism induced by the combination Nitrile 2 + curcumin was much stronger than the synergism promoted by the combination Nitrile 1 + curcumin (CI = 0.3843 vs 0.6622, respectively). Conclusions: The co-administration of dipeptide nitriles with curcumin enhances rhodesain inhibition through synergistic effects. Notably, Nitrile 2 + curcumin exhibits a stronger synergy at higher inhibition levels, indicating a greater therapeutic potential.Keywords
Funding Information
- PRIN_2022PNRR_P2022KCW3L_002 (CUP J53D23014810001)
This publication has 28 references indexed in Scilit:
- Effectiveness and safety of fexinidazole for gambiense human African trypanosomiasis and exploration of adherence in outpatients: a phase 3b, prospective, open-label, non-randomised, cohort studyThe Lancet Global Health, 2025
- Estimating the treatment effects of multiple drug combinations on multiple outcomes in hypertensionCell Reports Medicine, 2025
- New WHO guidelines for treating rhodesiense human African trypanosomiasis: expanded indications for fexinidazole and pentamidineThe Lancet Infectious Diseases, 2024
- Development of novel dipeptide nitriles as inhibitors of rhodesain of Trypanosoma brucei rhodesienseEuropean Journal of Medicinal Chemistry, 2022
- Drug Synergism: Studies of Combination of RK-52 and Curcumin against Rhodesain of Trypanosoma brucei rhodesienseACS Medicinal Chemistry Letters, 2020
- Human African trypanosomiasisThe Lancet, 2017
- Cysteine proteases of parasitic organismsMolecular and Biochemical Parasitology, 2002
- Active site mapping, biochemical properties and subcellular localization of rhodesain, the major cysteine protease of Trypanosoma brucei rhodesienseMolecular and Biochemical Parasitology, 2001
- Antigenic variation in trypanosomes: Enhanced phenotypic variation in a eukaryotic parasite2001
- Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitorsAdvances in Enzyme Regulation, 1984